Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The value of delayed (18)F FDG-PET imaging in diagnosis of solitary pulmonary nodules: A preliminary study on 28 patients.

Yang P, Xu XY, Liu XJ, Gong JS.

Quant Imaging Med Surg. 2011 Dec;1(1):31-4. doi: 10.3978/j.issn.2223-4292.2011.11.03.

2.

Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5.

Chen CJ, Lee BF, Yao WJ, Cheng L, Wu PS, Chu CL, Chiu NT.

AJR Am J Roentgenol. 2008 Aug;191(2):475-9. doi: 10.2214/AJR.07.3457.

PMID:
18647920
3.

Risk stratification of solitary pulmonary nodules by means of PET using (18)F-fluorodeoxyglucose and SUV quantification.

Grgic A, Yüksel Y, Gröschel A, Schäfers HJ, Sybrecht GW, Kirsch CM, Hellwig D.

Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1087-94. doi: 10.1007/s00259-010-1387-3. Epub 2010 Feb 6.

PMID:
20140611
4.

[Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].

Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X.

Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):364-8. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.010. Chinese.

PMID:
22883458
5.

Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography.

D'Souza MM, Marwaha RK, Sharma R, Jaimini A, Thomas S, Singh D, Jain M, Bhalla PJ, Tripathi M, Tiwari A, Mishra A, Mondal A, Tripathi RP.

Ann Nucl Med. 2010 Jun;24(5):345-55. doi: 10.1007/s12149-010-0357-y. Epub 2010 Apr 7.

PMID:
20373060
6.

Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.

Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Momose M, Nagai A, Ohnuki T, Nishikawa T, Kusakabe K.

J Nucl Med. 2006 Mar;47(3):426-31.

7.

Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.

Degirmenci B, Wilson D, Laymon CM, Becker C, Mason NS, Bencherif B, Agarwal A, Luketich J, Landreneau R, Avril N.

Nucl Med Commun. 2008 Jul;29(7):614-22. doi: 10.1097/MNM.0b013e3282f9b5a0.

PMID:
18528183
8.

Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions.

Tian R, Su M, Tian Y, Li F, Li L, Kuang A, Zeng J.

Skeletal Radiol. 2009 May;38(5):451-8. doi: 10.1007/s00256-008-0643-0. Epub 2009 Feb 10.

PMID:
19205695
9.

Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy.

Conrad GR, Sinha P.

Nucl Med Commun. 2003 Nov;24(11):1129-37.

PMID:
14569166
10.

Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules.

Alkhawaldeh K, Bural G, Kumar R, Alavi A.

Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):246-52. Epub 2007 Oct 16.

PMID:
17938921
12.

Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.

Christensen JA, Nathan MA, Mullan BP, Hartman TE, Swensen SJ, Lowe VJ.

AJR Am J Roentgenol. 2006 Nov;187(5):1361-7.

PMID:
17056930
13.

Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.

Orlacchio A, Schillaci O, Antonelli L, D'Urso S, Sergiacomi G, Nicolì P, Simonetti G.

Radiol Med. 2007 Mar;112(2):157-73. Epub 2007 Mar 19. English, Italian.

PMID:
17361379
14.

Solitary pulmonary nodules differentiated by dynamic F-18 FDG PET in a region with high prevalence of granulomatous disease.

Huang YE, Lu HI, Liu FY, Huang YJ, Lin MC, Chen CF, Wang PW.

J Radiat Res. 2012;53(2):306-12. Epub 2012 Feb 25.

15.

The diagnostic role of dual-phase (18)F-FDG PET/CT in the characterization of solitary pulmonary nodules.

Demir Y, Polack BD, Karaman C, Ozdoğan O, Sürücü E, Ayhan S, Akkoçlu A, Ozdemir N.

Nucl Med Commun. 2014 Mar;35(3):260-7. doi: 10.1097/MNM.0000000000000049.

PMID:
24468852
16.

Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.

Hickeson M, Yun M, Matthies A, Zhuang H, Adam LE, Lacorte L, Alavi A.

Eur J Nucl Med Mol Imaging. 2002 Dec;29(12):1639-47. Epub 2002 Oct 2.

PMID:
12458399
17.

Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.

Chun EJ, Lee HJ, Kang WJ, Kim KG, Goo JM, Park CM, Lee CH.

Lung Cancer. 2009 Aug;65(2):180-6. doi: 10.1016/j.lungcan.2008.11.015. Epub 2009 Jan 19.

PMID:
19155090
18.

Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.

Okada M, Shimono T, Komeya Y, Ando R, Kagawa Y, Katsube T, Kuwabara M, Yagyu Y, Kumano S, Imaoka I, Tsuchiya N, Ashikaga R, Hosono M, Murakami T.

Ann Nucl Med. 2009 Jun;23(4):349-54. doi: 10.1007/s12149-009-0246-4. Epub 2009 Apr 2.

PMID:
19340526
19.

Dual-time-point 18F-FDG PET imaging for diagnosis of disease type and disease activity in patients with idiopathic interstitial pneumonia.

Umeda Y, Demura Y, Ishizaki T, Ameshima S, Miyamori I, Saito Y, Tsuchida T, Fujibayashi Y, Okazawa H.

Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1121-30. doi: 10.1007/s00259-009-1069-1. Epub 2009 Feb 27.

PMID:
19247654
20.

Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients.

Schillaci O, Travascio L, Bolacchi F, Calabria F, Bruni C, Cicciò C, Guazzaroni M, Orlacchio A, Simonetti G.

Radiol Med. 2009 Sep;114(6):890-906. doi: 10.1007/s11547-009-0400-z. Epub 2009 Jul 4. English, Italian.

PMID:
19579015
Items per page

Supplemental Content

Write to the Help Desk